News
Dec 3, 2020 | In the Media, News
ICAP’s Elaine Abrams, MD, senior research director, was featured in a Nov 30 article in The New York Times, which reported that for the 80,000 children who die of H.I.V. each year, drugs are often bitter or hard to swallow. Dolutegravir will soon come in a tasty...
Dec 1, 2020 | News
A World AIDS Day Like No Other For more than 30 years, the annual observation of World AIDS Day on December 1 has given the global community an opportunity to pause and collectively reflect on the HIV pandemic – celebrating the strides we have made and sharpening our...
Nov 30, 2020 | News
ICAP at Columbia University announces two new awards from the National Institutes of Health (NIH) to support HIV prevention research in the US and globally. The first award enables the continued work of the NIH-funded HIV Prevention Trials Network (HPTN) through its...
Nov 25, 2020 | In the Media, News
ICAP’s Jessica Justman, MD, senior technical director, was featured in a Nov 23 article by MedicineNet, which reported the AztraZeneca vaccine shows effectiveness. The AstraZeneca vaccine becomes the third shot to show good effectiveness, following on the heels...
Nov 25, 2020 | In the Media, News
ICAP’s Jessica Justman, MD, senior technical director, was featured in a Nov. 24 article by Time Magazine, which discussed AztraZeneca’s COVID-19 vaccine and why its efficacy varies so much. The data, part of a scheduled efficacy review, is based on 131...
Nov 25, 2020 | In the Media, News
Wafaa El-Sadr, MD, MPH, MPA, global director of ICAP, was consulted for a Nov 23 article in the The Salt Lake Tribune which discussed how states that imposed fewer restrictions now have the worst outbreaks of COVID-19. Coronavirus cases are rising in almost every U.S....